Uitgebreide gids binnenkort beschikbaar
We werken aan een uitgebreide educatieve gids voor de Paracetamol Toxicity (Rumack-Matthew). Kom binnenkort terug voor stapsgewijze uitleg, formules, praktijkvoorbeelden en deskundige tips.
Acetaminophen (paracetamol) toxicity is the most common cause of acute liver failure in the United Kingdom and United States, responsible for over 50,000 emergency department visits annually in the USA alone. While acetaminophen is extremely safe at therapeutic doses (maximum 4g/day in adults), overdose saturates normal glucuronidation and sulphation detoxification pathways, shunting metabolism toward CYP2E1-mediated formation of the toxic reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI). NAPQI is normally detoxified by conjugation with hepatic glutathione, but in overdose, glutathione stores are depleted and NAPQI accumulates, causing oxidative hepatocellular damage. The Rumack-Matthew nomogram (1975) is the cornerstone tool for risk stratification: plotting the serum paracetamol concentration against time since ingestion on a semi-logarithmic graph determines whether the patient is above or below the treatment line. In the UK, the single treatment line is set at 100 mg/L at 4 hours post-ingestion and declines logarithmically; in the USA, the original treatment line is at 150 mcg/mL at 4 hours. Patients with levels above the treatment line require N-acetylcysteine (NAC) — the antidote that replenishes glutathione stores and directly scavenges NAPQI. The clinical course of acetaminophen toxicity progresses through four phases: (I) nausea, vomiting, malaise within 24h; (II) right upper quadrant pain and transaminase elevation at 24–72h; (III) peak hepatotoxicity with fulminant liver failure at 72–96h; (IV) either recovery or death from multi-organ failure by day 7.
Plot serum acetaminophen (mcg/mL or mg/L) vs time post-ingestion (h) on Rumack-Matthew nomogram; treatment line at 150 mcg/mL at 4h; treat with NAC if above line
- 1Step 1 — History: Establish exact time of ingestion, dose taken, formulation (immediate vs modified-release), co-ingestants, and risk factors for hepatotoxicity (alcohol use, enzyme induction, malnutrition, glutathione depletion).
- 2Step 2 — Blood tests at 4 hours: Serum paracetamol level (not valid before 4 hours post-ingestion), LFTs, INR, creatinine, electrolytes, venous blood gas, and blood glucose.
- 3Step 3 — Plot on Rumack-Matthew nomogram: Plot the serum concentration against time post-ingestion. In the UK, treat if above the 100 mg/L at 4h line; in the USA, treat if above 150 mcg/mL at 4h.
- 4Step 4 — Initiate NAC if indicated: IV N-acetylcysteine 150 mg/kg over 60 minutes (loading), then 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours (standard UK 21-hour regime). Oral NAC 140 mg/kg loading then 70 mg/kg q4h × 17 doses is an alternative.
- 5Step 5 — Repeat LFTs and INR at 24h: If ALT rising or INR prolonging, continue NAC and reassess liver function trajectory.
- 6Step 6 — King's College Criteria: Assess at 24–96h for fulminant liver failure indicators — pH <7.30, INR >6.5, creatinine >300 mcmol/L, grade III/IV encephalopathy — which predict need for emergency liver transplantation.
- 7Step 7 — Assess for modified-release paracetamol: Slow-release formulations (Panadol Osteo, Paradote) produce delayed peak serum levels. A 4-hour level may be normal; check at 4 hours AND 8 hours if modified-release suspected.
Loading: 150 mg/kg NAC × 60 kg = 9,000 mg over 60 min; continue full 21-hour regime
At 5 hours post-ingestion, the treatment line sits at approximately 140 mg/L. Level of 200 mg/L is above — treat. NAC loading dose = 150 × 60 = 9,000 mg (9g) in 200 mL 5% dextrose over 60 min.
Ensure psychiatric assessment; discharge with safety plan; LFTs only if symptomatic
Treatment line at 6h ≈ 100 mg/L (UK) or 110 mcg/mL (USA). Level of 75 mg/L is below — no NAC required. Confirm history is reliable. Observe 4h for symptom development.
When ingestion time is unknown, treat as if level is above line — risk of withholding NAC outweighs risk of treatment
The Rumack-Matthew nomogram requires a known ingestion time. If time is unknown, or if 4h has not elapsed, treatment with NAC is the safe default. NAC is extremely safe and the consequences of not treating are catastrophic.
Modified-release formulations have delayed peak serum concentration; a 4h level may be falsely reassuring
Standard nomogram is not validated for modified-release paracetamol. NPIS/TOXBASE recommend treating if 8h level ≥50 mg/L or if clinically concerned, irrespective of 4h result.
Emergency department risk stratification of deliberate self-harm paracetamol overdoses to guide NAC treatment. This application is commonly used by professionals who need precise quantitative analysis to support decision-making, budgeting, and strategic planning in their respective fields
Toxicology service consultation for staggered overdose, modified-release formulations, and high-risk patients. Industry practitioners rely on this calculation to benchmark performance, compare alternatives, and ensure compliance with established standards and regulatory requirements
Intensive care monitoring of fulminant liver failure progression and transplant listing using King's College Criteria. Academic researchers and students use this computation to validate theoretical models, complete coursework assignments, and develop deeper understanding of the underlying mathematical principles
Pharmacist and GP education on paracetamol dose limits for patients with chronic pain or comorbidities. Financial analysts and planners incorporate this calculation into their workflow to produce accurate forecasts, evaluate risk scenarios, and present data-driven recommendations to stakeholders
Forensic medicine and medico-legal assessment of paracetamol dosing in unexplained hepatotoxicity cases. This application is commonly used by professionals who need precise quantitative analysis to support decision-making, budgeting, and strategic planning in their respective fields
Staggered Overdose
Staggered overdose (multiple therapeutic or supra-therapeutic doses over time) is not assessable using the Rumack-Matthew nomogram. The nomogram is only valid for acute single ingestion at a known time. For staggered overdose, treat if total paracetamol dose in 24h exceeds 75 mg/kg (adults) or 150 mg/kg (children) regardless of serum level.
Paediatric Paracetamol Toxicity
Children under 5 years have a lower incidence of severe hepatotoxicity from paracetamol relative to adults, possibly due to preferential sulphation metabolism. The Rumack-Matthew nomogram is still used for risk stratification in children. NAC is weight-based and the same 21-hour IV protocol is used. Children are less likely to achieve truly toxic ingestions because they typically vomit.
Patients with Established Liver Disease
Patients with pre-existing liver disease (cirrhosis, hepatitis B/C, alcoholic liver disease) have reduced glutathione reserve and impaired detoxification capacity. The threshold for NAC treatment should be lower in these patients. Current UK guidance recommends using the standard treatment line — do not apply the old 'high-risk' line which was removed in 2012.
Anaphylactoid Reaction to NAC
IV NAC causes anaphylactoid reactions (histamine release — not IgE-mediated) in 10–20% of patients, typically during the loading infusion. Features: flushing, urticaria, nausea, bronchospasm. Manage by stopping infusion, IV antihistamine (chlorphenamine 10 mg IV), and restarting at the next lower rate. True anaphylaxis is rare. Do NOT stop NAC permanently — it is life-saving.
| Phase | Time | Clinical Features |
|---|---|---|
| Phase I | 0–24h | Nausea, vomiting, malaise, pallor; LFTs normal |
| Phase II | 24–72h | RUQ pain, tender hepatomegaly; ALT/AST begin rising; INR may extend |
| Phase III | 72–96h | Peak hepatotoxicity — fulminant liver failure, encephalopathy, coagulopathy, hypoglycaemia, renal failure |
| Phase IV | 4–14 days | Recovery (majority) or death from multi-organ failure / successful transplant |
How does N-acetylcysteine work as an antidote?
NAC replenishes hepatic glutathione stores (as a precursor to cysteine, a glutathione building block) and directly conjugates with NAPQI to form non-toxic cysteine and mercapturate conjugates. It also improves hepatic microcirculatory blood flow and has direct antioxidant and anti-inflammatory properties. It is most effective within 8 hours of ingestion but provides benefit even at 24–36 hours in established hepatotoxicity.
What are risk factors for paracetamol hepatotoxicity?
Factors that increase NAPQI production or decrease glutathione: chronic alcohol use (induces CYP2E1, depletes glutathione), enzyme-inducing medications (rifampicin, carbamazepine, phenytoin, St John's Wort), malnutrition, eating disorders, and HIV/AIDS. The UK formerly used a higher-risk nomogram line for these patients, but current MHRA guidance uses a single treatment line for all patients.
What are the King's College Criteria for liver transplantation?
King's College Criteria (paracetamol-specific): arterial pH <7.30 after resuscitation (regardless of encephalopathy grade), OR all three of: INR >6.5, creatinine >300 mcmol/L, and grade III/IV hepatic encephalopathy. Meeting criteria predicts <10% 1-year survival without transplantation. Transplant referral should occur before all three criteria are met if trajectory is deteriorating. This is an important consideration when working with acetaminophen toxicity calculations in practical applications.
Why is the treatment line set at 4 hours post-ingestion?
Serum paracetamol levels before 4 hours are unreliable because absorption from the gut is still occurring and distribution is not yet complete. A pre-4-hour level may be falsely reassuring. The 4-hour level represents the peak plasma concentration from which the Rumack-Matthew nomogram plots the expected decline based on normal hepatic metabolism kinetics.
What if the patient presents more than 24 hours post-ingestion?
After 24 hours, the serum paracetamol level becomes less useful as a guide. Management is based on LFTs, INR, creatinine, and clinical features. If there is any biochemical evidence of hepatotoxicity (ALT >normal), NAC should be continued. Fulminant liver failure risk is highest at 72–96 hours — intensive care and transplant team involvement is required.
Can paracetamol toxicity occur at therapeutic doses?
Rarely, hepatotoxicity can occur at near-therapeutic doses in patients with risk factors (chronic alcohol use, malnutrition, enzyme inducers). This 'therapeutic misadventure' typically presents later and more insidiously. Intentional overdose with acute high-dose ingestion is far more common. Any patient with unexplained transaminase elevation should have paracetamol history taken. This is an important consideration when working with acetaminophen toxicity calculations in practical applications.
What is the RUCAM score and its relevance to paracetamol?
The Roussel Uclaf Causality Assessment Method (RUCAM) is a structured scoring tool for attributing drug-induced liver injury (DILI) to a specific medication. In paracetamol toxicity, causality is usually clear from history and nomogram, so RUCAM is more applicable in non-paracetamol DILI where multiple drugs are involved. RUCAM scores 1–2 = excluded, 3–5 = possible, 6–8 = probable, >8 = highly probable.
Is activated charcoal useful in paracetamol overdose?
Activated charcoal 50g (or 1g/kg in children) is recommended within 1 hour of significant paracetamol ingestion to reduce gut absorption. Beyond 1 hour, benefit is minimal for immediate-release formulations. For modified-release preparations, charcoal may be beneficial up to 2–4 hours. Charcoal is contraindicated if airway is unprotected or if co-ingestants preclude its use.
Pro Tip
The Rumack-Matthew nomogram only applies to acute single-time-point ingestion of immediate-release paracetamol at a known time. When in doubt, treat with NAC — it is one of medicine's safest antidotes and the consequences of withholding treatment are catastrophic. Always check the NPIS (UK) or Poison Control (USA) helpline for complex cases.
Wist je dat?
Paracetamol (acetaminophen) was first used clinically in 1955, marketed as Tylenol. The mechanism of its hepatotoxicity — NAPQI formation and glutathione depletion — was not understood until the 1970s. The Rumack-Matthew nomogram was published in 1975, the same year NAC was approved as the antidote, making paracetamol overdose one of the first toxicological emergencies to have both a validated risk stratification tool and a specific antidote developed simultaneously.
Referenties